Cargando…

Intravenous Zoledronate 4 mg for the treatment of post-menopausal osteoporosis: A prospective open-labeled study

BACKGROUND: Zoledronate 5 mg intravenous (IV) annually is approved for treatment of post-menopausal osteoporosis. Zoledronate 4 mg which is approved for the treatment of cancer related hypercalcemia can be an alternative for Asian women who have smaller stature. OBJECTIVES: To examine the efficacy a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arunthanachaikul, Thunyawarin, Chaiamnuay, Sumapa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Full Length Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8651995/ https://www.ncbi.nlm.nih.gov/pubmed/34926731 http://dx.doi.org/10.1016/j.bonr.2021.101153

Ejemplares similares

The efficacy of intra-articular triamcinolone acetonide 10 mg vs. 40 mg in patients with knee osteoarthritis: a non-inferiority, randomized, controlled, double-blind, multicenter study
por: Utamawatin, Komchan, et al.
Publicado: (2023)

Six monthly intravenous zoledronic acid in childhood osteoporosis
por: Munns, CF, et al.
Publicado: (2013)

Blended internet care for patients with severe mental illnesses: An open label prospective controlled cohort pilot study
por: Blankers, Matthijs, et al.
Publicado: (2016)

Denosumab versus zoledronate for the treatment of low bone mineral density in male HIV-infected patients
por: Makras, Polyzois, et al.
Publicado: (2021)

Cortical porosity is elevated after a single dose of zoledronate in two rodent models of chronic kidney disease
por: Swallow, Elizabeth A., et al.
Publicado: (2022)

Physically Targeted Intravenous Polyurethane Nanoparticles for Controlled Release of Atorvastatin Calcium
por: Eftekhari, Behnaz Sadat, et al.
Publicado: (2017)

Open-Label Placebo Treatment: Outcome Expectations and General Acceptance in the Lay Population
por: Haas, Julia W., et al.
Publicado: (2020)

Treatment of Transient Osteoporosis of the Hip with Intravenous Zoledronate - A Case Report -
por: Seok, Hyun, et al.
Publicado: (2011)

Intravenous zoledronic acid for the treatment of osteoporosis: The evidence of its therapeutic effect
por: Lewiecki, E Michael
Publicado: (2010)

Utility of iliac crest tetracycline-labelled bone biopsy in osteoporosis and metabolic bone disease: An evaluation of 95 cases over a period of 25 years
por: Colazo, Juan M., et al.
Publicado: (2023)

Pharmacokinetics and Biodistribution of Rhopalurus junceus Scorpion Venom in Tumor-Bearing Mice after Intravenous and Oral Administration
por: Díaz-García, Alexis, et al.
Publicado: (2019)

Efficacy of cenobamate for uncontrolled focal seizures: Post hoc analysis of a Phase 3, multicenter, open‐label study
por: Sperling, Michael R., et al.
Publicado: (2021)

Intravenous zoledronate for postmenopausal women with osteopenia and osteoporosis: a systematic review and metanalysis
por: Gazoni, Fernanda Martins, et al.
Publicado: (2023)

Modifying the osteoblastic niche with zoledronic acid in vivo—Potential implications for breast cancer bone metastasis
por: Haider, Marie-Therese, et al.
Publicado: (2014)

Necrobiotic xanthogranuloma scleritis in a case of granulomatosis with polyangiitis (Wegener’s granulomatosis)
por: Keorochana, Narumon, et al.
Publicado: (2017)

Effect of patient education on medication adherence of patients with rheumatoid arthritis: a randomized controlled trial
por: Taibanguay, Nichapa, et al.
Publicado: (2019)

Group B streptococcus is the most common pathogen for septic arthritis with unique clinical characteristics: data from 12 years retrospective cohort study
por: Ruksasakul, Rungkan, et al.
Publicado: (2019)

Adverse childhood experiences interact with inflammation and menopause transition stage to predict verbal memory in women
por: Metcalf, Christina A., et al.
Publicado: (2022)

The prospects of waste management in the hospitality sector post COVID-19
por: Filimonau, Viachaslau
Publicado: (2021)

Favorable therapeutic response of osteoporosis patients to treatment with intravenous zoledronate compared with oral alendronate
por: Al-Bogami, Mohammed M., et al.
Publicado: (2015)

Quality of life in post-menopausal osteoporosis
por: Bianchi, Maria Luisa, et al.
Publicado: (2005)

Oral Therapeutics Post Menopausal Osteoporosis
por: Schroeder, Ryan J, et al.
Publicado: (2023)

Collagenase clostridium histolyticum in patients with Dupuytren’s contracture: results from POINT X, an open-label study of clinical and patient-reported outcomes
por: Warwick, D., et al.
Publicado: (2015)

Enoxaparin for outpatients with COVID-19: 90-day results from the randomised, open-label, parallel-group, multinational, phase III OVID trial
por: Voci, Davide, et al.
Publicado: (2023)

Focal osteoporosis defects play a key role in hip fracture
por: Poole, Kenneth E.S., et al.
Publicado: (2017)

Low dose hydrophilic statins are the preferred agents for females at risk of osteoporosis
por: Antonenko, Alisa, et al.
Publicado: (2021)

Distribution of the CM-Dil-Labeled Human Umbilical Cord Vein Mesenchymal Stem Cells Migrated to the Cyclophosphamide-Injured Ovaries in C57BL/6 Mice
por: Jalalie, Ladan, et al.
Publicado: (2019)

Post hoc analysis of a phase 3, multicenter, open‐label study of cenobamate for treatment of uncontrolled focal seizures: Effects of dose adjustments of concomitant antiseizure medications
por: Rosenfeld, William E., et al.
Publicado: (2021)

Glucocorticoid Withdrawal Symptoms and Quality of Life in Patients with Systemic Lupus Erythematosus
por: Karoonkatima, Matee, et al.
Publicado: (2023)

Open‐label long‐term treatment of add‐on triheptanoin in adults with drug‐resistant epilepsy
por: Borges, Karin, et al.
Publicado: (2020)

Long‐term cannabidiol treatment in patients with Dravet syndrome: An open‐label extension trial
por: Devinsky, Orrin, et al.
Publicado: (2018)

Cannabidiol in patients with Lennox‐Gastaut syndrome: Interim analysis of an open‐label extension study
por: Thiele, Elizabeth, et al.
Publicado: (2019)

Effect of 2 mg Versus 4 mg of Intravenous Zoledronic Acid on Bone Mineral Density at the Lumbar Spine in Indian Postmenopausal Women with Osteoporosis: A Double-blind Parallel-arm Randomized Controlled Trial
por: Durgia, Harsh, et al.
Publicado: (2021)

POST-MENOPAUSAL OSTEOPOROSIS: Has it been medicalized?
por: Hogg, C. Alison
Publicado: (1997)

T cells and post menopausal osteoporosis in murine models
por: Pacifici, Roberto
Publicado: (2007)

Frailty syndrome in women with osteoporosis, should physicians consider screening? A cross-sectional study
por: Rahimipour Anaraki, Shiva, et al.
Publicado: (2023)

User characteristics and usage of an open access moderated internet support group for depression and other mental disorders: A prospective study
por: Griffiths, Kathleen M, et al.
Publicado: (2016)

Citric acid-modified pH-sensitive bone-targeted delivery of estrogen for the treatment of postmenopausal osteoporosis
por: Chen, Zhong-Hua, et al.
Publicado: (2023)

Woodchuck Hepatitis Virus Post-Transcriptional Regulation Element (WPRE) Promotes Anti-CD19 BiTE Expression in Expi293 Cells
por: Moazzami, Reza, et al.
Publicado: (2021)

Genetic variation in WNT16 and its association with bone mineral density, fractures and osteoporosis in children with bone fragility()
por: Mäkitie, R.E., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_df49s45fgnj2nh2av7ioappq2m